Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 4.193.336 |
|
|||||
| News | - | ||||||
| Tageshoch | 9,59 | Niedrig Hoch |
|||||
| Tagestief | 9,22 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Adma Biologics Inc | ADMA | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,21 | 2,28% | 9,42 | 01:58:48 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 9,23 | 9,22 | 9,59 | 9,41 | 9,21 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 22.786 | 4.193.336 | US$ 9,48 | US$ 39.755.214 | - | 3,06 - 9,59 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:59:14 | 1 | US$ 9,50 | USD |
Option-Flow Adma Biologics (ADMA)
Finanzwerte ADMA
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 2,15B | 228,22M | - | 258,22M | -28,24M | -0,12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Adma Biologics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 17.5.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.5.2024 | 23:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09.5.2024 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.5.2024 | 22:05 | GlobeNewswire Inc. | ADMA Biologics Announces First Quarter 2024 Financial.. |
| 09.5.2024 | 13:47 | IH Market News | U.S. Index Futures Dip, Bank of England Holds Interest Rates.. |
| 02.5.2024 | 13:00 | GlobeNewswire Inc. | ADMA Biologics to Report First Quarter 2024 Financial.. |
| 11.3.2024 | 21:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11.3.2024 | 17:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 11.3.2024 | 12:00 | GlobeNewswire Inc. | ADMA Biologics Announces FDA Approvals of Extended Room.. |
| 09.3.2024 | 03:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.3.2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.3.2024 | 13:00 | GlobeNewswire Inc. | ADMA Biologics to Participate in the Raymond James.. |
Forum Adma Biologics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ADMA Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 8,80 | 9,59 | 8,4233 | 9,04 | 3.572.126 | 0,62 | 7,05% |
| 1 Monat | 6,30 | 9,59 | 6,19 | 7,79 | 3.022.109 | 3,12 | 49,52% |
| 3 Monate | 5,25 | 9,59 | 5,08 | 6,68 | 2.937.349 | 4,17 | 79,43% |
| 6 Monate | 3,96 | 9,59 | 3,60 | 5,82 | 2.496.305 | 5,46 | 137,88% |
| 1 Jahr | 4,12 | 9,59 | 3,06 | 4,90 | 2.283.058 | 5,30 | 128,64% |
| 3 Jahre | 1,77 | 9,59 | 1,01 | 3,04 | 2.554.338 | 7,65 | 432,20% |
| 5 Jahre | 4,09 | 9,59 | 1,01 | 2,87 | 2.792.707 | 5,33 | 130,32% |
